(0.18%) 5 140.75 points
(0.18%) 38 512 points
(0.26%) 17 893 points
(-0.87%) $83.12
(1.82%) $1.958
(0.02%) $2 347.60
(0.14%) $27.57
(0.61%) $927.75
(-0.22%) $0.933
(-0.22%) $11.00
(-0.29%) $0.798
(1.14%) $92.92
Live Chart Being Loaded With Signals
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications...
Stats | |
---|---|
今日成交量 | 27.00 |
平均成交量 | 4 492.00 |
市值 | 234.62M |
EPS | £0 ( 2024-03-24 ) |
Last Dividend | £62.00 ( 2023-04-06 ) |
Next Dividend | £0 ( N/A ) |
P/E | 27.58 |
ATR14 | £16.17 (0.36%) |
Bioventix PLC 财务报表
Annual | 2022 |
营收: | £12.82M |
毛利润: | £11.86M (92.53 %) |
EPS: | £1.610 |
FY | 2022 |
营收: | £12.82M |
毛利润: | £11.86M (92.53 %) |
EPS: | £1.610 |
FY | 2022 |
营收: | £11.72M |
毛利润: | £11.01M (93.94 %) |
EPS: | £1.470 |
FY | 2021 |
营收: | £10.93M |
毛利润: | £10.11M (92.52 %) |
EPS: | £1.303 |
Financial Reports:
No articles found.
Bioventix PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£26.00 (N/A) |
£0 (N/A) |
£62.00 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £14.40 | 2014-10-16 |
Last Dividend | £62.00 | 2023-04-06 |
Next Dividend | £0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 18 | -- |
Total Paid Out | £610.50 | -- |
Avg. Dividend % Per Year | 1.28% | -- |
Score | 4.07 | -- |
Div. Sustainability Score | 9.02 | |
Div.Growth Potential Score | 6.87 | |
Div. Directional Score | 7.94 | -- |
Year | Amount | Yield |
---|---|---|
2014 | £14.40 | 2.42% |
2015 | £32.60 | 4.47% |
2016 | £36.50 | 2.89% |
2017 | £60.00 | 4.44% |
2018 | £80.00 | 3.23% |
2019 | £77.00 | 2.51% |
2020 | £89.00 | 2.68% |
2021 | £81.00 | 1.82% |
2022 | £78.00 | 2.29% |
2023 | £62.00 | 1.50% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TPT.L | Dividend Knight | 2023-06-08 | Annually | 27 | 2.93% | |
MATE.L | Dividend Knight | 2023-06-29 | Quarterly | 7 | 2.31% | |
CRN.L | Dividend King | 2023-09-14 | Annually | 6 | 3.87% | |
RWS.L | Dividend Knight | 2023-06-22 | Semi-Annually | 21 | 1.50% | |
HMSO.L | Dividend Junior | 2023-08-24 | Annually | 32 | 1.96% | |
BBGI.L | Dividend Knight | 2023-09-07 | Semi-Annually | 13 | 2.94% | |
VSL.L | Dividend Knight | 2023-09-07 | Quarterly | 10 | 5.70% | |
MTVW.L | Dividend Knight | 2023-07-06 | Semi-Annually | 32 | 2.55% | |
DSCV.L | Dividend Knight | 2023-06-22 | Annually | 33 | 0.73% | |
SMDS.L | Dividend Knight | 2023-09-07 | Semi-Annually | 32 | 2.56% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.637 | 1.500 | 10.00 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.659 | 1.200 | 10.00 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.738 | 1.500 | 2.92 | 4.37 | [0.1 - 1] |
payoutRatioTTM | 0.915 | -1.000 | 0.847 | -0.847 | [0 - 1] |
currentRatioTTM | 7.04 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 6.69 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 3.22 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.562 | 2.00 | 9.48 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.561 | 2.00 | 9.22 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.928 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.789 | 1.000 | 10.00 | 10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 1.034 | 0.800 | 6.44 | 5.15 | [0.5 - 2] |
Total Score | 9.02 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 26.80 | 1.000 | 7.39 | 0 | [1 - 100] |
returnOnEquityTTM | 0.738 | 2.50 | 5.45 | 4.37 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.561 | 2.00 | 9.48 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.55 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.562 | 2.00 | 9.48 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.915 | 1.500 | 0.847 | -0.847 | [0 - 1] |
pegRatioTTM | 281.43 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.600 | 1.000 | 10.00 | 0 | [0.1 - 0.5] |
Total Score | 6.87 |
Bioventix PLC
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in London, the United Kingdom.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。